✦ LIBER ✦

Individualized dosimetry in patients undergoing therapy with177Lu-DOTA-D-Phe1-Tyr3-octreotate

✍ Scribed by Mattias Sandström; Ulrike Garske; Dan Granberg; Anders Sundin; Hans Lundqvist

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bone marrow dosimetry in peptide recepto

✍ Flavio Forrer; Eric P. Krenning; Peter P. Kooij; Bert F. Bernard; Mark Konijnenb 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 219 KB

177Lu-[DOTA0,Tyr3] octreotate therapy in

✍ Michael Garkavij; Mattias Nickel; Katarina Sjögreen-Gleisner; Michael Ljungberg; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB

[177Lu-DOTA0,Tyr3]octreotate: comparison

✍ Dik J. Kwekkeboom; Willem H. Bakker; Peter P. Kooij; Mark W. Konijnenberg; Anant 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 96 KB

[177Lu-DOTA0-Tyr3]-Octreotate Treatment

✍ Christina Swärd; Peter Bernhardt; Håkan Ahlman; Bo Wängberg; Eva Forssell-Aronss 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 178 KB

Comparison of sequential planar177Lu-DOT

✍ Aurora Sainz-Esteban; Vikas Prasad; Christiane Schuchardt; Carolin Zachert; José 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 444 KB

Pre-therapeutic dosimetry and biodistrib

✍ Andreas Helisch; Gregor J. Förster; Helmut Reber; Hans-Georg Buchholz; Rudolf Ar 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 357 KB